Back to search

University of Washington

Interpreting variation in pharmacogenes using multiplex assays

Abstract

dc:description.abstract

With the advent of genome sequencing technologies, our ability to read DNA sequences is unprecedented. However, understanding how the variation we encounter impacts humans is a formidable challenge. Technologies like multiplex assays, in which we can measure tens of thousands of variants in a high-throughput, pooled manner, allow us to tackle this problem at scale. In particular, genes that are involved in drug response, called pharmacogenes, pose a unique opportunity to apply multiplex assays. These assays would not only help us better understand pharmacogene biology, they would also provide vital evidence for tailoring drug regimens to a patient’s genotype. To advance towards this goal, in Chapter 1, I give an introduction to multiplex assays and outline what pharmacogenes we should prioritize for this approach. In Chapter 2, I detail how I used multiplex assays to interrogate the biology of vitamin K epoxide reductase (VKOR), the target of warfarin. By applying assays for abundance and activity to VKOR, I suggest a resolution for the controversy over VKOR topology, identify residues that are functionally constrained in the protein, and interpret human variants found in genomic databases. In Chapter 3, I show how applying an abundance assay to cytochrome P450 2C9 (CYP2C9) identifies highly conserved core regions of the protein and the show that 42% of missense variants present in genome databases have decreased abundance, suggesting that drug metabolism may be affected in individuals with these variants. Finally, in chapter 4, I outline challenges in designing multiplex assays for pharmacogenes, including tackling combinatorial variation, and comment on the promising future of pharmacogenomics.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Chiasson, Melissa
Advisor dc:contributor.advisor
  • Fowler, Douglas M

Subjects

dc:subject × 1

Rights

dc:rights
Statement dc:rights
  • CC BY-NC-SA
Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1773/46017

Chain of custody

source
Harvested from
University of Washington
Base URL
digital.lib.washington.edu/server/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Chiasson, Melissa. Interpreting variation in pharmacogenes using multiplex assays. 2020. http://hdl.handle.net/1773/46017